Related Experiment Video
Updated: Jul 18, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
IL-2 gene C/T polymorphism is associated with prostate cancer
Hsi-Chin Wu1, Chao-Hsiang Chang, Lei Wan
1Department of Urology, China Medical University Hospital, Taichung, Taiwan.
Genetic variations in the interleukin-2 (IL-2) gene are linked to prostate cancer susceptibility. The TT genotype of the IL-2 gene was more prevalent in prostate cancer patients, suggesting a potential association.
Area of Science:
- Genetics
- Oncology
- Immunology
Background:
- Cytokines play a role in prostate cancer development.
- Interleukin-2 (IL-2) and its receptor are key components of the immune system.
Purpose of the Study:
- To investigate the association between C/T polymorphisms in the IL-2 and IL-2 receptor beta (IL-2RB) genes and prostate cancer risk.
- To analyze the correlation between these genetic variations and patient survival.
Main Methods:
- Case-control study comparing IL-2 and IL-2RB gene polymorphisms in 96 prostate cancer patients and 105 healthy controls.
- Genotype frequencies were analyzed.
- Survival analysis was performed over a 5-year follow-up period.
Main Results:
- A significant difference in IL-2 gene genotype distribution was observed between prostate cancer patients and controls (P=0.017).
- The TT genotype of the IL-2 gene was significantly more frequent in the cancer group (32.3%) compared to the control group (16.2%).
- No significant association was found between IL-2 gene polymorphism and survival, nor between IL-2RB gene polymorphism and prostate cancer.
Conclusions:
- The IL-2 gene C/T polymorphism may be associated with prostate cancer susceptibility in the Taiwan population.
- IL-2RB gene polymorphism does not appear to be associated with prostate cancer risk.
- Further research is needed to confirm these findings and elucidate the underlying mechanisms.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

